Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

162
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
162
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

262
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
262
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

200
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
200
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

265
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
265
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

363
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
363

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lead fraction transformation drives microbial functional recovery and coupled nutrient cycling-metal resistance networks in Pb-Zn tailings.

Journal of hazardous materials·2026
Same author

Ribosome stress meets disulfidptosis: HOIL-1 safeguards cell fate during nutrient deprivation.

Cell death and differentiation·2026
Same author

Sorafenib Restores Pentose Phosphate Pathway-Related Redox Homeostasis via the c-Raf/HSP90/G6PD Axis in Hepatic Ischemia-Reperfusion Injury.

MedComm·2026
Same author

Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance.

Cell·2026
Same author

Physical activity, resilience, and mental health in adolescents: a systematic review of recent evidence.

Frontiers in sports and active living·2026
Same author

Effects of physical activity and resilience on anxiety in China children: a mediating model with moderating effects.

Frontiers in sports and active living·2026

相关实验视频

Updated: Jul 18, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K

下一代结核病疫苗:进展,挑战和前景

Li Zhuang1,2, Zhaoyang Ye2, Linsheng Li2

  • 1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, Eighth Medical Center of Chinese PLA General Hospital, Beijing 100091, China.

Vaccines
|August 26, 2023
PubMed
概括

开发新的结核病 (TB) 疫苗至关重要,因为目前的Bacillus Calmette-Guérin (BCG) 疫苗的疗效有限. 了解宿主-病原体相互作用是推动新型结核病疫苗研究的关键.

关键词:
结核杆菌菌菌 (MTB) 的结核病临床试验是指临床试验中的临床试验.深度学习是一种深度学习.结核病 (TB) 是一种疾病.疫苗,疫苗的使用情况.

更多相关视频

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.0K
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.4K

相关实验视频

Last Updated: Jul 18, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.0K
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

9.4K

科学领域:

  • 免疫学 免疫学 免疫学
  • 传染性疾病 传染性疾病
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 由Mycobacterium tuberculosis (MTB) 引起的结核病 (TB) 仍然是一个重大的全球卫生挑战.
  • 现有的Bacillus Calmette-Guérin (BCG) 疫苗提供有限的保护,特别是在成年人中.
  • 一个世纪的研究尚未产生一种普遍有效的结核病疫苗.

研究的目的:

  • 审查结核病疫苗开发当前面临的挑战.
  • 强调宿主-病原体相互作用机制对于新型疫苗设计的重要性.
  • 总结结核结核疫苗研究的进展和未来方向.

主要方法:

  • 关于结核病疫苗研究的综合文献综述.
  • 在临床前和临床开发中对各种结核病疫苗候选人的评估.
  • 分析开发新型结核病疫苗的障碍和机遇.

主要成果:

  • 确定了结核病疫苗研究中的关键障碍.
  • 评估了多种不同的疫苗平台,包括mRNA和病毒样粒子 (VLP) 疫苗.
  • 强调了宿主-病原体相互作用在指导未来研究中的关键作用.

结论:

  • 新型结核病疫苗的开发需要对宿主-病原体相互作用有更深入的了解.
  • 像mRNA和VLP这样的新兴疫苗技术显示出有希望.
  • 持续的研究和探索新的策略对于有效打击结核病至关重要.